DarioHealth expands its payer network with a new Blue Cross
Blue Shield agreement, bolstering recurring revenue growth and
reinforcing its position in one of healthcare's fastest-growing
sectors; Dario's AI-driven digital health platform continues to
drive adoption among payers seeking scalable, data-driven
solutions
NEW
YORK, Feb. 6, 2025 /PRNewswire/ -- DarioHealth
Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the
global digital health market, today announced that it has secured a
new agreement with a Blue Cross Blue Shield (BCBS) health plan,
marking a significant expansion of its presence in the health plan
market. The program, rolled out in January
2025, allows members seamless access to Dario's
evidence-based, AI-driven health coaching and monitoring tools.
This agreement will integrate the Dario platform's comprehensive
cardiometabolic digital health solutions, including programs for
diabetes, hypertension, and weight management, into the health
plan's suite of member services offered to employers. The agreement
is already contributing to the Company's annual recurring revenue
(ARR) in Q1 2025, and as with many of the contracts launched in
January of 2025, the relationship with this health plan is expected
to expand further throughout the year to cover more of the plan's
population.
This new collaboration with a BCBS-affiliated plan, a trusted
leader in healthcare across the U.S., reinforces Dario's expanding
role in delivering digital cardiometabolic care solutions
nationwide. With this agreement, Dario now serves nine health
plans, spanning both regional and national payers. As the
cardiometabolic disease market is projected to surpass $1.2 trillion by 20331, this latest
expansion strengthens Dario's position in one of healthcare's
fastest growing and most financially significant sectors.
"We believe that this expansion highlights the increasing demand
among payers for scalable, AI-driven digital health solutions that
deliver measurable health improvements and cost efficiencies," said
Steven Nelson, Chief Commercial
Officer at Dario. " We believe that securing another Blue Cross
Blue Shield health plan further validates our market leadership in
cardiometabolic care and reinforces our ability to scale recurring
revenue growth. With nine health plans now leveraging our
technology, we are rapidly expanding our presence in the
multi-billion-dollar payer market and strengthening our
trajectory toward profitability and long-term growth."
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health
company revolutionizing how people with chronic conditions manage
their health through a user-centric, multi-chronic condition
digital therapeutics platform. Dario's platform and suite of
solutions deliver personalized and dynamic interventions driven by
data analytics and one-on-one coaching for diabetes, hypertension,
weight management, musculoskeletal pain and behavioral
health.
Dario's user-centric platform offers people continuous and
customized care for their health, disrupting the traditional
episodic approach to healthcare. This approach empowers people to
holistically adapt their lifestyles for sustainable behavior
change, driving exceptional user satisfaction, retention and
results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to
health plans and other payers, self-insured employers, providers of
care and consumers. To learn more about Dario and its digital
health solutions, or for more information, visit
http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. related thereto contain or may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements that
are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it
discusses the integration of the Dario platform's digital
health solutions into the BCBS health plan, the expectancy
that relationship the Company's current health plans will expand
further throughout the year to cover more populations, the
Company's expanding role in delivering digital cardiometabolic care
solutions nationwide, projections with respect to the
cardiometabolic disease market, the increasing demand among payers
for scalable, AI-driven digital health solutions, and the Company's
ability to scale recurring revenue growth, profitability and
long-term growth. Without limiting the generality of the foregoing,
words such as "plan," "project," "potential," "seek," "may,"
"will," "expect," "believe," "anticipate," "intend," "could,"
"estimate" or "continue" are intended to identify forward-looking
statements. Readers are cautioned that certain important factors
may affect the Company's actual results and could cause such
results to differ materially from any forward-looking statements
that may be made in this news release. Factors that may affect the
Company's results include, but are not limited to, regulatory
approvals, product demand, market acceptance, impact of competitive
products and prices, product development, commercialization or
technological difficulties, the success or failure of negotiations
and trade, legal, social and economic risks, and the risks
associated with the adequacy of existing cash resources. Additional
factors that could cause or contribute to differences between the
Company's actual results and forward-looking statements include,
but are not limited to, those risks discussed in the Company's
filings with the U.S. Securities and Exchange Commission. Readers
are cautioned that actual results (including, without limitation,
the timing for and results of the Company's commercial and
regulatory plans for Dario™ as described herein) may differ
significantly from those set forth in the forward-looking
statements. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
applicable law.
1https://straitsresearch.com/report/cardiometabolic-disease-market
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat
Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Logo:
https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/dariohealth-announces-new-blue-cross-blue-shield-agreement-expanding-health-plan-client-base-302370044.html
SOURCE DarioHealth Corp.
